CMA Intermediate · Financial Management and Business Data Analytics · Cost of Capital
A data analyst at a Mumbai firm reviews the firm's marginal cost of capital schedule. Which statement about the concept is correct?
Marginal cost of capital is the weighted cost of the next rupee of new capital raised. It normally rises as more is raised because cheaper sources like retained earnings run out and costlier external funds are needed.
- AMarginal cost of capital is the historical average of past financing costs weighted by book values
- BMarginal cost of capital is the weighted cost of the next rupee of new capital raised, and it normally rises as larger amounts are raisedCorrect
- CMarginal cost of capital is always equal to the cost of retained earnings
- DMarginal cost of capital falls continuously as more capital is raised because of tax shield on equity
Explanation
Marginal cost of capital is the weighted average cost of raising an additional rupee of new funds, using target or market weights. It typically rises beyond certain amounts as cheaper sources such as retained earnings are exhausted and costlier new equity or debt is needed. Historical book-value averages describe the existing cost, not the marginal one.
Did you get it right without looking?
One question tells you little. A timed set on Cost of Capital shows your real accuracy, how long you take and where you lose marks.
More Cost of Capital questions
- Kaveri Auto Ltd has a risk-free return of 7%, an expected market return of 13% and an equity beta of 1.2. Under the CAPM approach, what is i…
- A data analyst compares the cost of preference capital with the after-tax cost of debt for a firm at a 25% tax rate. Which statement about p…
- Sundaram Textiles Ltd has issued 12% irredeemable preference shares of face value ₹100, each sold in the market at ₹96 with no issue costs. …
- Narmada Chemicals Ltd has a current share price of Rs 150. Its EPS is Rs 15, and it follows a constant 40% payout policy. Retained earnings …
- Meera Pharma Ltd has equity ₹600 lakh (cost 15%), 10% preference ₹100 lakh issued at par (cost 10%) and 12% debentures ₹300 lakh at par, wit…
- Sundaram Pharma Ltd issues 10% redeemable preference shares of ₹100 face value at par, redeemable after 5 years at par, with no issue costs.…